Glyceryl - trinitrate
PreclinicalSmall molecule
Glyceryl - trinitrate is one of 53 small molecule programs targeting Anal fissure. It is currently in Preclinical.
3
Indications
10
Total Trials
0
Active Trials
52
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
174 competitors in Schizophrenia
#DrugCompanyPhaseTrials
1Resotran
TakedaPreclinical
Inapsine
Jazz PharmaceuticalsPreclinical
Ozempic
Novo NordiskPreclinical
Depakote
AbbViePreclinical
Ibrance
PfizerPreclinical
Lunesta
Akero TherapeuticsPreclinical
Luvox
SSolvay Pharmaceuticals
Preclinical
Catapres
Boehringer IngelheimPreclinical
Rapamune
PPrism Pharmaceuticals
Preclinical
Persantine
Boehringer IngelheimPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Anal fissure2 trials
Tendinopathy1 trial
4 more indications
Pancreatitis1 trial
Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP)
Terminated·—·Phase 2/3·NCT00419549·371 enrolled
Angina Pectoris1 trial
Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris
Unknown status·GGuang'anmen Hospital of China Academy of Chinese Medical Sciences·Phase 4·NCT04661709·502 enrolled
Erectile Dysfunction1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Glyceryl - trinitrate. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- PProcris Pharmaceuticals